CRN’s supplement survey, OmniActive’s new acquisition, SABPA report, NPA on NMN

USA:​ Supplement use remains at 75%, interest increases in specialty products​

Three quarters of Americans continue to use dietary supplements, according to the 2024 Consumer Survey conducted by Ipsos and sponsored by the Council for Responsible Nutrition.

This is consistent with 2023 numbers, but CRN noted that the survey highlights subtle shifts towards specific products as the market moves toward precision health approaches.

“We continue to see consumers exploring new specialty products and embrace personalized health solutions,” said Jeff Ventura, senior vice president of communications at CRN. “This speaks to the evolving landscape of wellness, where supplements are becoming more integrated into individualized health practices.”

According to the survey, 69% of respondents said they look for a personalized regimen when choosing their products. Among users under the age of 55, Black and Asian Americans are more likely seek out personalized solutions when selecting a dietary supplement.

The reasons for supplement use remain also consistent with 2023 data—42% of consumers list overall health and wellness as a motivation for supplementation. Immune health and energy are factors contributing to use in 30% and 27% of consumers, respectively.

Click HERE​ for more information.

India: OmniActive acquires ENovate Biolife​

OmniActive Health Technologies has acquired ENovate Biolife, expanding its ingredients portfolio to target key health categories in the dietary supplement space.

The agreement, finalized on Oct. 26, builds on the success of an initial 2019 partnership between the two companies through a U.S. licensing agreement for enXtra, a clinically studied Alpinia Galanga ingredient marketed to support mental energy.